Tick-borne encephalitis virus codes for two major immunogenic polypeptides, one of which is the major virion envelope protein E, and the other, NV3, does not have a designated function at present. The intracellular forms of both the E and NV3 polypeptides contain at least four types of sugar residues, i.e. galactose, glucosamine, fucose and mannose. The only glycoprotein in the extracellular virion particles is E. Experiments performed in the presence of tunicamycin have demonstrated that most of these sugars are N-linked. The kinetics of synthesis of E and NV3 have been studied and both show a distinct lag period between initiation of protein synthesis and the appearance of either protein.
INTRODUCTION
Tick-borne encephalitis is the most important arthropod-borne human disease in Europe and is caused by a member of the Flaviviridae family of viruses which includes other important human pathogens causing diseases such as yellow fever, dengue fever, Japanese encephalitis and St. Louis encephalitis. Flaviviruses code for three virion structural proteins, the core protein (C), a major envelope protein (E) and a minor envelope protein (M) or its precursor (preM) (for review, see Russell et aL, 1980) . Neither the C nor the M proteins of any flavivirus have been shown to be glycosylated, but the E proteins of dengue-2 virus (Stollar, 1969) , Japanese encephalitis virus (Shapiro et aL, 1972) and yellow fever virus (Schlesinger et al., 1983) have been shown to contain sugar residues. Furthermore, amino acid sequences derived from the cloned cDNA of yellow fever virus E protein contain two sites at which N-glycosylation could occur (Rice et al., 1985) . With Kunjin virus (Wright, 1982) and West Nile virus however, radiolabelled sugars have not been detected in the E protein from purified virus preparations, although radiolabelled sugars were reported to be incorporated into putative intracellular precursors of the E protein from both these viruses (Wright & Warr, 1985) . The amino acid sequence of the E protein of West Nile virus does not contain any potential Nglycosylation sites although radiolabelled sugars can be detected in the NV2 polypeptide (the precursor of M) in extracellular virus, and the amino acid sequence of NV2 does contain Nglycosylation sites .
Tick-borne encephalitis virus (TBEV) particles contain a single core protein (C) and two envelope proteins E and M (Heinz & Kunz, 1977) . Infected cells on the other hand contain two major immunogens (the E and 51K polypeptides) and two minor immunogens (the 37K and 23K polypeptides) (Hambleton et aL, 1983) . The E polypeptide of TBEV contains epitopes that bind to antibodies with neutralizing (NT), protective, haemagglutination-inhibiting (HI) and 0000-7487 © 1987 SGM antibody-dependent plaque enhancement (ADPE) activities (Heinz et al., 1983; Stephenson et al., 1984; Phillpotts et al., 1985) . The 51K polypeptide appears to contain only epitopes binding antibodies with ADPE activities (Stephenson et al., 1984; Phillpotts et al., 1985) , although recent experiments in our laboratory have detected complement-fixing epitopes on the 51K polypeptide as well as on the E polypeptide (Phillpotts et al., 1986) .
In this report we present evidence that both the major immunogens of TBEV contain several sugar residues, at least some of which are N-linked. The virion does not contain NV2 and the virion E polypeptides are glycosylated. The kinetics of synthesis of the E and 51K polypeptides, and the time course for their appearance in infected cells, are described.
METHODS
Viruses and cells. The Neud6rfl isolate of TBEV (clone H) was obtained from Dr C. Wiblin of this Institute. Virus inocula and porcine kidney (PS) cells were prepared as described previously (Stephenson et al., 1984) .
Preparation of radioactive cell lysates. Monolayers of PS cells (2 x 106 cells per sample) were infected at 35 °C with TBEV suspensions at an m.o.i, of approximately 5 x 102. At 21 h post-infection (except where otherwise indicated), the medium was replaced with phosphate-buffered saline (PBS) and the cells were incubated for 2 h at 35 °C. The PBS was then replaced with fresh PBS containing either [3SS]methionine at 250 ktCi/ml or 3H-labelled sugars at 1 mCi/ml. At the end of the desired labelling period, either 1 ml of sample buffer (8 M-urea, 2 ~ SDS, 1 2-mercaptoethanol) or 1 ml of radioimmune precipitation (RIP) buffer (0.15 M-NaCI, 10 mM-Tris-HC1 pH 8.0, 1 mM-EDTA, 0-01 ~ sodium azide, 1 ~ Nonidet P-40, aprotinin 500 units/ml) (Stephenson et al., 1980) was added.
All samples were immediately stored at -20 °C. Antigens for radioimmune affinity chromatography (RIAC) were prepared as described by Stephenson & ter Meulen (1979) for RIP, except that the 100000 g centrifugation step was omitted.
Radioimmune affinity chromatography. Aliquots (250 l.tl) of cell lysates or clarified cell supernatants were incubated overnight at 4 °C with either 20 p.l monoclonal antibody solution (0.5 mg/ml in sterile PBS) or 2 tll of serum. The reaction mixture was then incubated at 4 °C for 1 h with 30 gl of a saturated suspension of Protein ASepharose 4B (0.3 g/ml) with occasional gentle agitation. The gel slurry was made up to 1 ml with RIP buffer, poured onto a disposable column (Wright Scientific, U.K.), drained and washed with two 10 ml volumes of wash buffer (10 mM-Tris-HC1 pH 8.5; 150 mM-NaC1; 1 mM-EDTA; sodium azide, 0.01 ~ w/v; Nonidet P-40, 0.01%; aprotinin 500 units/ml), The column was drained, and the sample was then eluted with 200 ~1 of sample buffer, boiled for 1 min and either stored at -20 °C or used for PAGE analyses.
Polyacrylamidegelelectrophoresis. Samples were run for 2 h at 250 V on either 15 ~ or 7 ~ discontinuous SDS gels under denaturing conditions as described by Stephenson et al. (1977) .
Preparation of rabbit sera. Hyperimmune rabbit sera were prepared against partially purified virus preparations as described by Hambleton et al. (1983) . Sera against cell lysates were prepared as follows. Infected cell lysates were prepared as described above but without incorporating radioactive tracers. All lysates and virus preparations were inactivated by incubating them with 0.05 % formalin at 37 °C for 30 min. The lysates were then diluted 10-fold in wash buffer without sodium azide and mixed with an equal volume of Freund's complete adjuvant. The rabbits were inoculated at multiple intradermal sites and boosted 14 days and 28 days later. Fourteen days after the final boost the rabbits were bled, serum was prepared and stored at -20 °C.
14C-methylated protein molecular weight markers were obtained from Amersham. Protein A-linked Sepharose 4B was from Pharmacia Fine Chemicals and tunicamycin from Sigma.
RESULTS

Identity of sugar-containing virus specific polypeptides
When PS cells are infected with TBEV, they produce 10 infected cell-specific polypeptides, with apparent molecular weights of 81K, 73K, 69K, 65K, 58K, 51K, 25K, 18K, 15K and 12K (Fig. l, lane 2) . This polypeptide profile corresponds well with that obtained in avian cells by Heinz & Kunz (1982) . The only major difference between the two cell types is that one additional polypeptide (12K) is seen in our experiments in porcine cells. Of these virus-specific polypeptides, only three are capable of incorporating radiolabelled galactose (Fig. 1, lane 4) i.e. those with apparent mol. wt. 58K, 51K and 25K. These polypeptides are also capable of incorporating radiolabelled mannose and glucosamine ( Fig. 1 , lanes 6 and 8), but fucose could only be detected in the 58K and 51K polypeptides. Radiolabelled glucose was also incorporated into these polypeptides (data not shown), but the interpretation of this observation is uncertain as it could not be guaranteed that the tritium atoms were still attached to glucose moieties; indeed, under certain experimental conditions all virus-specific polypeptides could be shown to contain tritium derived from radiolabelled glucose. The 58K polypeptide is assumed to be the E protein from virus particles as it is specifically precipitated by a monoclonal antibody, T9, (Fig.  2 , lanes 1 and 3) which demonstrates neutralizing and protective functions (Stephenson et al., 1984; Phillpotts et al., 1986) and also specifically precipitates the E protein from purified virus particles (see below). Although the role of the 51K polypeptide is not known at present, it is a major viral immunogen (Hambleton et al., 1983) and is probably analogous to the NV3 intracellular polypeptide described for several other flaviviruses. The identity of the 25K polypeptide is not known at present, but it could be similar to the NV2 polypeptide described for yellow fever virus and West Nile virus and would thus be an intracellular precursor to M.
Glycoproteins in virion particles
Recent reports on West Nile virus and Kunjin virus (Wright, 1982) have shown that not all flavivirus envelope proteins are glycosylated. It is of interest therefore to determine whether any of the TBEV glycoproteins appear in virion particles. The PS cells were labelled with 3H-labelled galactose and extracellular virus particles were purified on sucrose gradients as described by Heinz & Kunz (1977) . Gradient fractions containing infectious virus particles were pooled, the virus was pelleted by centrifugation and analysed by P A G E as described in Methods (Fig. 3) . Virus particles prepared in this manner contained the virion proteins E and C when labelled with [3sS]methionine, but when labelled with [3H]galactose only the E polypeptide could be detected. The 25K polypeptide (NV2) was never detected in extracellular virion particles.
Kinetics of glycoprotein synthesis
The post-translational modification of glycoproteins is largely dependent on the compartments in the cell through which they pass. As this process requires a finite amount of time, it is necessary to determine the kinetics of their synthesis as a first step in understanding various stages in their synthesis and modification. As TBEV fails to shut offefficiently the synthesis of most host proteins (Fig. 1) , the kinetics of glycoprotein synthesis was studied by using the relevant monoclonal antibodies in RIAC analysis. This methodology was developed because the two virus-specified polypeptides NV5 and NV4 were frequently non-specifically precipitated in classical RIP analyses. Protein synthesis was first synchronized by hypertonic salt treatment (335 raM) for 30 rain and proteins were labelled with [35S]methionine on release of the hypertonic block. Results from a typical experiment are shown in Fig. 4 (a) and demonstrate that the E glycoprotein can be detected after 30 min labelling, although occasionally a faint band is seen after 20 min. This lag in synthesis is unexpected as a protein of this size would be expected to appear after 1 to 2 min labelling, and indeed other TBEV-specific proteins, notably NV5 and NV4, can be detected in total cell lysates only 2 min after release of the hypertonic block (data not shown). The 51K polypeptide appeared even later, normally 45 min after release from the hypertonic block (Fig. 4b) .The lag period observed in the synthesis of both these proteins could indicate the occurrence of a precursor whose modification takes a finite amount of time, or it may be an indication that the antigenic structure of these proteins that is recognized by the monoclonal antibodies depends on the presence of the sugar residues and, as this is dependent upon transport along the endoplasmic reticulum, this explains the apparent lag in synthesis. Experiments to examine both these hypotheses are presented below.
Kinetics of synthesis in the presence of tunicamycin
In order to determine whether the monoclonal antibodies could detect unglycosylated TBEV proteins or their precursors with an efficiency equal to that of their glycosylated counterparts, the kinetics of synthesis of the two major immunogens were analysed using lysates from cells treated with the glycosylation inhibitor tunicamycin. Both the E-specific monoclonal antibody (T9) and the 51 K-specific monoclonal antibody (T 12) were capable of binding efficiently to the unglycosylated forms of the relevant proteins (Fig. 5) . As with the glycosylated proteins, there was a distinct lag in the synthesis of the unglycosylated fbrms of both E and 51K. The molecular weight of the 51K polypeptide was substantially reduced in the presence of tunicamycin, indicating substantial amounts of N-linked sugar residues on this protein. The apparent mol. wt. of the E glycoprotein was only slightly reduced when synthesized in the presence of tunicamycin, but this can be seen more clearly when samples are run on 7% gels (Fig. 6 ). It is also obvious from Fig. 6 that the band of protein from untreated cells is much broader than that observed with protein from treated cells, again indicative of glycosylation of E.
Search for precursors
The inability to detect precursors in the above experiments could be due to several additional factors. The epitope to which the antibody binds could be buried in the precursor molecule or, if it is conformational in nature, it could be only recognized in the mature, fully processed molecule. In an attempt to circumvent these problems, we raised polyclonal rabbit sera to infected cell lysates and used them to detect virus-specific proteins. The results shown in Fig. 7 demonstrate the same lag in synthesis of E and NV3 reported in Fig. 4 and 5. Although small amounts of other virus-specific proteins were precipitated, no additional bands, which were not precipitated from uninfected cells could be detected (data not shown). Thus no evidence was obtained for the existence of any precursor molecules to either E or NV3.
Time course of protein synthesis
As TBEV does not shut off host protein synthesis efficiently, monoclonal antibodies must be used to detect virus-specific glycoproteins at early stages in the infectious cycle. Cell lysates were therefore prepared at various times after infection and reacted with T9 or T12 in a RIAC assay (Fig. 8) . The synthesis of the E and 51K glycoproteins can be detected as early as 6 h after infection. The levels of synthesis of both proteins rise until a maximum is reached at 15 h postinfection after which they remain stable.
DISCUSSION
An understanding of the synthetic processes leading to the production of the major flavivirus immunogens is of paramount importance in the development of new vaccines against these agents. Although the complete nucleotide sequences of both yellow fever virus and West Nile virus are now available, the mechanisms whereby flaviviruses replicate are still not understood. Furthermore, the function of most of the virus-specified polypeptides is not known including that of the second major immunogen, NV3. In addition, recent studies with several flaviviruses Fig. 4 ; lane 3, sample from tunicamycin-treated cells, prepared as in Fig. 5 . Mol. wt. markers are shown on the right hand side. Fig. 7 . Kinetics of TBEV protein synthesis. Samples were prepared as in Fig. 4 , purified by RIAC using an infected cell-specific antiserum and analysed by PAGE. Lanes designated as in Fig. 4. have demonstrated that whereas the major virion envelope protein is glycosylated in some flaviviruses, this does not appear to be the case in at least two others, namely West Nile virus and Kunjin virus.
Some of these questions have been approached by analysing the synthesis and posttranslational modification of TBEV in a porcine kidney cell line. When these cells are infected with TBEV, 10 virus-specific polypeptides can be detected. The species with molecular weights of 81K and 65K can be readily identified as the counterparts of NV5 and NV4 from yellow fever virus, and the 58K and 51K polypeptides as the counterparts to the E glycoprotein and the NV3 glycoprotein. The species migrating at 25K is possibly the equivalent to NV2 and that at 15K comigrates with the virion capsid protein C. The M protein cannot be detected in these experiments possibly because it does not contain methionine; indeed preliminary sequence analysis of these regions of the genome has failed to detect methionine codons.
The nucleotide sequence of yellow fever virus R N A identified four possible additional nonstructural proteins Ns4a, Ns4b, Ns2a and Ns2b. If the 15K polypeptide is an intracellular form of C, then the 73K, 69K, 18K and 12K polypeptides could be candidates for the four additional non-structural polypeptides. The experiments reported here show that of the 10 polypeptide species found specifically in infected cells, only three (E, NV3 and NV2) contain sugar residues. These studies show that the intracellular form of E contains at least four types of sugar residue, i.e. galactose, glucosamine, mannose and fucose and that the E molecules found in virion particles are also glycosylated. Thus TBEV resembles yellow fever virus, in that the major virion envelope protein is glycosylated and that NV2 is not found in the virion particle. Unfortunately, M is not present in large enough amounts in the purified virion particles to exclude the possible presence of sugar residues in it. However nucleotide sequence analyses of the regions of the genome coding for the M protein of yellow fever virus (Rice et al., 1985) , West Nile virus and Murray Valley encephalitis virus (Dalgarno et al., 1986) support the hypothesis that the M protein of TBEV is unglycosylated. Our studies have also shown that the other major immunogen (51K polypeptide) is also glycosylated and contains all four sugars found in E, whereas NV2 appears to contain only galactose, mannose and glucosamine. Experiments performed in the presence of tunicamycin indicate that at least some of the sugars on E and NV3 are N-linked. The kinetics of synthesis of the major immunogens, E and NV3, have been analysed by employing a hypertonic salt block in order to synchronize protein synthesis, and RIAC with specific monoclonal antibodies in order to overcome the high background due to host cell protein synthesis. These experiments reveal a lag of at least 20 min before E is detected and at least 30 min before NV3 is detected. As polypeptides of this size normally require only 1 or 2 min to be synthesized, some other process must need to occur after chain elongation has started and before the mature polypeptide is detected. One possible explanation is that, assuming the TBEV genome is similar in construction to those of yellow fever virus and West Nile virus, the ribosome binds to the only initiation codon at the 5' end of the genomic RNA and then scans along the polycistl ~nic messenger until the desired point is reached before polypeptide synthesis is commenced. It seems unlikely that such a process occurs here as no internal initiation codons have been found and 20 to 30 min seems a long time for such a process to take place. A more plausible explanation would be that the ribosome initiates at the first AUG, translates the C protein and the signal peptide of preM with the subsequent insertion of the nascent polypeptide into the membrane of endoplasmic reticulum (Rice et al., 1985) . The ribosome then proceeds to translate preM and M, but as the cleavage between preM and M appears to require a host protease similar to that found in the Golgi apparatus (Bell et al., 1985 ; Rice & Strauss, 1981 ) the messenger RNA-ribosome complex may have to wait until it is translocated to the Golgi apparatus before preM and M can be cleaved and translation of E can commence. As the translocation to this organelle takes about 30 min, such a mechanism would adequately explain the delay in appearance of E after the synchronous initiation of protein synthesis. A similar translocation-dependent cleavage between E and M or E and the N terminus of NV3 could similarly account for the further delay in the appearance of NV3. Thus a series of proteolytic cleavages which are dependent upon translocation to various specific sites in the host cell could explain not only the lag in synthesis of these proteins but also the failure to find any high mol. wt. precursors to them in infected cells. Such an intimate link between cellular location and synthesis may have been forced on the virus as E and NV3 require the hydrophobic terminus of the preceding protein to ensure their correct location in the cell membrane.
Experiments to study the formation of both these proteins throughout the course of infection reveal that both proteins can be detected as early as 6 h after infection and in some experiments small amounts can be seen as early as 3 h after infection. Thus there is no evidence at present for the temporal control of virus protein synthesis as eeen with influenza virus.
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